Skip to content

Botulinum-assisted Orbital Fat Augmentation With PRP (Platelet-rich-plasma)

Botulinum-assisted Orbital Fat Augmentation With PRP (Platelet-rich-plasma)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02244671
Enrollment
6
Registered
2014-09-19
Start date
2014-01-31
Completion date
2018-01-03
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orbital Atrophy

Brief summary

immobilization of yoked extra-ocular muscles in the anophthalmic orbit, in conjunction with platelet-rich-plasma, will improve integration of viable adipocytes injected into orbital fat

Detailed description

Immobilization of tissue (graft, graft bed) is a prerequisite for tissue integration. Since yoked extra-ocular muscles continue to be stimulated by movements of the seeing eye after fat injection into the anophthalmic orbit, the use of botulinum toxin(s) can be used to prevent movement of the orbital tissue bed(s) and improve anchoring of injected fat. Platelet rich plasma may also improve fat cell anchoring by the action of fibrin on the adhesion process. This innovation builds on the results of IRB protocols 10.27 and 12.01 as registered with Clinical Trials.gov

Interventions

PROCEDUREfat, PRP, botulinum toxin

fat injection with platelet-rich-plasma (PRP) after immobilizing the extraocular muscles with botulinum toxin

DRUGbotulinum toxin

botulinum toxin used to immobilize extra-ocular muscles prior to fat injection.

DEVICEPRP

autologous PRP is prepared with a dedicated centrifuge at the time of fat harvesting

Sponsors

Fox, Donald Munro, M.D., P.C.
Lead SponsorINDIV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* anophthalmic enophthalmos in subjects within a 50 mile radius of New York City, grade 0-1 anesthesia risk, ages 21-75

Exclusion criteria

* radiated orbits

Design outcomes

Primary

MeasureTime frameDescription
Orbital volumeone yearAugmentation of orbital volume accessed with clinical photographs and non-contrast MRI

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026